Performance of the Applied Biosystems ViroSeq Human Immunodeficiency Virus Type 1 (HIV-1) Genotyping System for Sequence-Based Analysis of HIV-1 in Pediatric Plasma Samples

Author:

Cunningham Shawn1,Ank Bonnie2,Lewis Dan3,Lu Wei3,Wantman Michael4,Dileanis JoAnn5,Jackson J. Brooks1,Palumbo Paul3,Krogstad Paul2,Eshleman Susan H.1

Affiliation:

1. Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland1;

2. Department of Pediatrics, University of California at Los Angeles School of Medicine, Los Angeles,2 and

3. Department of Pediatrics, University of Medicine and Dentistry of New Jersey, Newark, New Jersey3; and

4. Statistical Data Analysis Center, Harvard School of Public Health, Boston, Massachusetts4

5. Applied Biosystems, Foster City,5California;

Abstract

ABSTRACT The ViroSeq HIV-1 Genotyping System is a commercially available, integrated sequence-based system for analysis of human immunodeficiency virus type 1 (HIV-1) drug resistance. We evaluated the performance of this system by analyzing HIV-1 in pediatric plasma samples. Plasma samples from children 4 months to 17 years of age were obtained from a clinical trial protocol (PACTG 377). Children in PACTG 377 were randomized to four treatment arms, including different combinations of antiretroviral drugs. HIV-1 genotyping was performed using samples collected prior to antiretroviral therapy (baseline) and at the time of virologic failure. Performance of the genotyping system was compared in three university laboratories. A total of 196 samples were analyzed, including 135 baseline and 61 failure samples. Plasma volumes ranged from 0.05 to 0.5 ml, and viral loads ranged from 1,084 to 3,484,991 copies/ml. PCR products suitable for sequencing were obtained for 192 of the 196 samples. Complete sequences for protease and reverse transcriptase were obtained for all of these 192 samples. For 180 samples, data were obtained from both DNA strands for the entire region analyzed. There was no evidence of sample cross-contamination based on phylogenetic analysis of HIV-1 sequences. Performance of the genotyping system was similar in three laboratories. This genotyping system performs well for analysis of HIV-1 in pediatric plasma samples, including those with low volume and low viral load. The availability of this system should facilitate studies of HIV-1 drug resistance.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Reference13 articles.

1. Selective vertical transmission of HIV-1 antiretroviral resistance mutations;Colgrove R. C.;AIDS,1998

2. Dileanis J. Marlowe N. Hoo B. Brown R. C. Bulmer M. Huang D. Palumbo P. Schuurman R. Van Laethem K. Vandamme A.-M. Elbeik T. Performance of the new ViroSeq HIV-1 Genotyping System (version 2) with group M subtype panel and with subtype B clinical research samples at test sites.5th International Congress on Drug Therapy in HIV Infection Glasgow United Kingdom2000

3. Effects of zidovudine use during pregnancy on resistance and vertical transmission of human immunodeficiency virus type 1;Frenkel L. M.;Clin. Infect. Dis.,1995

4. Sexual transmission of an HIV-1 variant resistant to multiple reverse transcriptase and protease inhibitors;Hecht F. M.;N. Engl. J. Med.,1998

5. Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an international AIDS society–USA panel;Hirsch M. S.;JAMA,2000

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3